Abstract:
Un antígeno para detectar la enfermedad celíaca, que comprende una gliadina recombinante desamidada quecomprende un dímero o trímero de SEC ID NO:1, en el que la gliadina recombinante desamidada está unidacovalentemente a una etiqueta formando una proteína de fusión de gliadina, en la que la etiqueta está inmovilizadasobre un soporte sólido.
Abstract:
The present invention provides methods and reagents for detecting antibodies against phospholipid-cofactor proteins. Phospholipids include cardiolipin. Cofactor proteins include beta-2-glycoprotein-1 (i.e., apolipoprotein H) or a prothrombin protein. Detection is accomplished with flow cytometry (e.g., fluorescence-activated cell sorting, facs).
Abstract:
The present invention provides methods and reagents for detecting antibodies against phospholipid-cofactor proteins. Phospholipids include cardiolipin. Cofactor proteins include beta-2-glycoprotein-1 (i.e., apolipoprotein H) or a prothrombin protein. Detection is accomplished with flow cytometry (e.g., fluorescence-activated cell sorting, facs).
Abstract:
The present invention provides methods and reagents for detecting antibodies against phospholipid-cofactor proteins. Phospholipids include cardiolipin. Cofactor proteins include beta-2-glycoprotein-1 (i.e., apolipoprotein H) or a prothrombin protein. Detection is accomplished with flow cytometry (e.g., fluorescence-activated cell sorting, facs).
Abstract:
The present invention provides methods and reagents for detecting antibodies against phospholipid-cofactor proteins. Phospholipids include cardiolipin. Cofactor proteins include beta-2-glycoprotein-1 (i.e., apolipoprotein H) or a prothrombin protein. Detection is accomplished with flow cytometry (e.g., fluorescence-activated cell sorting, facs).